Objectives
- 1.
Explain how the Na + pump uses energy from ATP to keep [Na + ] i low and [K + ] i high by transporting Na + and K + against their electrochemical gradients.
- 2.
Explain how Ca 2+ is sequestered in the sarcoplasmic and endoplasmic reticulum and transported across the plasma membrane by ATP-dependent active transport systems.
- 3.
Describe how intracellular Ca 2+ is controlled and Ca 2+ signaling is regulated by the cooperative action of many transport systems.
- 4.
Describe the roles of ATP-dependent transport systems in the transport of such ions as protons and copper, as well as a variety of other solutes.
- 5.
Explain how different transport systems in the apical and basolateral membranes of epithelia, which separate two different extracellular compartments, act cooperatively to effect net transfer of solutes and water across epithelial cells.
Primary active transport converts the chemical energy from ATP into electrochemical potential energy stored in solute gradients
In Chapter 10 , we learned how energy stored in the Na + electrochemical gradient can be used to generate concentration (or electrochemical) gradients for other (coupled) solutes. This is called secondary active transport because there is no net expenditure of metabolic energy by these transporters.
The question we now address is: How is the Na + concentration gradient (typically, [Na + ] o /[Na + ] i ≈ 10 to 15) established? This brings us to the role of ATP in powering primary active transport . During active ion transport, adenosine triphosphatases (ATPases) interconvert chemical energy stored in phosphate bonds and electrochemical potential energy stored in ion gradients. These straightforward chemical reactions can, depending on the concentrations of substrates and products, operate in either the forward or the reverse direction; that is, they can either use (hydrolyze) or synthesize ATP.
Three broad classes of ATPases are involved in active ion transport
The three classes of ion transport ATPases are the F- , V- , and P-type ATPases . Mitochondria possess F-type (F 1 F 0 ) ATPases that use energy stored in the proton electrochemical gradient across the inner mitochondrial membrane to synthesize ATP; the proton gradient is generated by oxidative metabolism. Vacuolar (V-type) H + -ATPases lower intraorganellar pH by concentrating protons in a variety of vesicular organelles, including lysosomes and secretory and storage vesicles. Neither the F-type nor the V-type ATPases form stable phosphorylated intermediates. In contrast, P-type ATPases do form stable phosphorylated intermediates in which the terminal phosphate of ATP has been transferred to an aspartyl residue on the ATPase (see page 118). The P-type ATPases selectively transport various, ions and other solutes into and out of cells and organelles. Examples of P-type ATPases are the plasma membrane (PM) Na + pump (Na + ,K + -ATPase), the PM and sarcoplasmic reticulum/endoplasmic reticulum (S/ER) Ca 2+ -ATPases (PMCA and SERCA, respectively), and the gastric mucosa proton pump (H + ,K + -ATPase). These P-type ATPases are the focus of much of this chapter.
The plasma membrane Na + pump (Na + ,K + -ATPase) maintains the low Na + and high K + concentrations in the cytosol
Nearly all animal cells normally maintain a high intracellular K + concentration and a low intracellular Na + concentration
In most cells in mammals, including humans, [K + ] i ≈ 120–130 mM, and [Na + ] i ≈ 5–15 mM. The extracellular fluid, however, has a high [Na + ] o (∼145 mM) and a low [K + ] o (∼4–5 mM). Moreover, cells are not impermeable to Na + and K: Na + and K + channels and Na + gradient–dependent transport systems ( Chapters 7 and 10 ) permit Na + to enter cells and K + to exit as the ions move down their respective electrochemical gradients. Therefore all cells expend energy in the form of ATP to generate and maintain their normal Na + and K + electrochemical gradients. The transporter that accomplishes this work is the sodium pump or Na + ,K + -ATPase . In the nervous system and the kidneys, the Na + pump accounts for about 75%–85% of total ATP hydrolysis. The transport of Na + and K + by the Na + pump compensates for the leak of these ions into and out of the cell, respectively. This is known as the pump-leak mechanism of Na + and K + homeostasis. The Na + pump not only maintains constant [Na + ] i and [K + ] i , but also maintains cell volume. How it does this is addressed in the next section.
The Na + pump hydrolyzes ATP while transporting Na + out of the cell and K + into the cell
The Na + pump is an integral PM protein whose major (α, or catalytic) subunit has 10 membrane-spanning helices ( Fig. 11.1 ) and contains the ATP and ion-binding sites. The α-subunit is closely associated with a smaller, highly glycosylated, β-subunit that has a single membrane-spanning domain. Complexes of α- and β-subunits, in a 1:1 ratio, are required for Na + pump activity, but how the β-subunit functions is unknown. The Na + pump is frequently called the Na + ,K + -ATPase because the protein is an enzyme (specifically, an ATPase) that requires both Na + and K + for its catalytic activity (ATP hydrolysis). a
a The Na + ,K + -ATPase was identified in 1957 by Jens Skou. He was awarded the Nobel Prize for this work in 1997.
The Na + pump hydrolyzes one ATP molecule to ADP and inorganic phosphate (P i ) while transporting three Na + ions out of the cell and two K + ions into the cell. The transport cycle begins with the binding of ATP (as a Mg 2+ -ATP complex) at the hydrolytic site on the α-subunit ( Fig. 11.1 ). When three Na + ions bind to the pump on the cytoplasmic side, the ATP is cleaved and its terminal phosphate is transferred to the α-subunit, forming a phosphorylated intermediate. This phosphorylation enables the protein to undergo a conformational change so that the bound Na + becomes transiently inaccessible (“occluded”) to both the cytoplasm and the extracellular fluid (ECF). The Na + -binding site then opens to the ECF. This conformational change also markedly reduces the Na + affinity, while greatly increasing K + affinity. Thus the three Na + ions are able to dissociate even though [Na + ] o ≈ 145 mM. Then, when two K + ions bind, the protein undergoes another conformational change. As the α-subunit–phosphate bond is cleaved, P i is released into the cytoplasm, and the K + -binding sites close to the ECF and become transiently occluded, and then open to the cytoplasm. The two K + ions are released into the cytoplasm because the affinity for K + decreases markedly during this conformational change. This sequence of steps in the Na + pump cycle is illustrated in Fig. 11.2 A.
The net reaction for the Na + pump can be written as:
3Nacyt++2 KECF++1 ATPcyt⇌3 NaECF++2 Kcyt++1 ADPcyt+1 Pi,cyt
and can be diagrammed as shown in Fig. 11.2 B. Note that this chemical reaction is reversible and can generate ATP if the product concentrations are greatly increased and the substrate concentrations are greatly reduced.
As a result of the 3 Na + :2 K + coupling ratio, inhibition of the Na + pump will lead to a net gain of solute (as Na + salts, to maintain electroneutrality) and a rise in osmotic pressure. The cells will therefore gain water and swell (see discussion of the Donnan effect in Chapter 4 ). Thus the Na + pump also is essential for maintaining cell volume (this is the “pump-leak mechanism”).
The Na + pump is “electrogenic”
The reaction sequence ( Equation 11.1 ) reveals that during each Na + pump cycle, one more positive charge leaves the cell than enters. This net flow of charge (i.e., outward “pump current”) across the membrane generates a small voltage (cytoplasm negative). The Na + pump is therefore said to be electrogenic. Indeed, this voltage adds to the V m , so that the actual resting V m is slightly more negative than the V m calculated from the GHK equation ( Chapter 4 ). The maximum voltage that can be generated by the Na + pump with a coupling ratio of 3 Na + :2 K + , under steady-state conditions, is approximately 10 mV. In practice, however, the contribution of the electrogenic Na + pump to the resting V m (i.e., in the steady state) in most cells is only a few millivolts (1–4 mV) and is usually ignored. When [Na + ] i rises significantly, as in neurons after a long burst of action potentials, the rate of Na + transport by the Na + pump can increase considerably. Under these non–steady-state conditions, the Na + pump may transiently hyperpolarize the cells by 20 mV or more, thereby temporarily reducing the ability of stimuli to excite the cells.
The Na + pump is the receptor for cardiotonic steroids such as ouabain and digoxin
The Na + pump α-subunit is uniquely sensitive to a class of drugs known as cardiotonic steroids . Two examples, digoxin and ouabain , were originally discovered in plants, but ouabain also is synthesized in humans and other mammals and is increasingly recognized as a hormone ( Box 11.1 ). Cardiotonic steroids inhibit the Na + pump and, as described later, thereby induce a cardiotonic effect (increased force of contraction of the heart, or positive inotropic effect ). This is the key to cardiotonic steroid therapeutic efficacy in heart failure. In addition, ouabain binding to the Na + pump can initiate cellular signaling by activating various protein kinase cascades that modulate protein expression and phosphorylation.
The cardiotonic steroids (CTSs) derive their name from the fact that they improve the performance of the heart. Digoxin comes from the leaves of the foxglove plant, Digitalis purpurea, and ouabain comes from the bark of the ouabaio tree, Acokanthera ouabaio. Some pharmacologically related CTSs, the bufadienolides, are produced by poisonous toads of the genus Bufo. Digitalis steroids, such as digoxin, have been used clinically to treat heart failure and certain cardiac arrhythmias for more than 200 years, and they are still used frequently. Digoxin is lipid soluble; it can be administered orally and is readily absorbed. Ouabain is not used clinically in the U.S. because it is relatively water soluble and, thus, poorly absorbed.
All cells have Na + pumps with a CTS-binding site whose physiological significance is only now being recognized. Surprisingly, ouabain, long used in poison darts by Maasai warriors in East Africa, has been identified as a mammalian hormone that is synthesized in the adrenal cortex and the hypothalamus. High dietary NaCl and Na + retention usually lead to high blood pressure (hypertension), and “endogenous ouabain” and α2 Na + pumps may be critical links between the retained Na + and the enhanced arterial constriction. Indeed, about 40% of patients with essential hypertension (i.e., hypertension of unknown cause) have significantly higher blood plasma levels of ouabain than are found in normotensive subjects (i.e., those with normal blood pressure). Moreover, chronic subcutaneous administration of ouabain, but not digoxin, induces hypertension in rodents; indeed, digoxin counteracts this effect of ouabain. The Na + pump inhibition by ouabain promotes vasoconstriction (a “vasotonic effect” analogous to the cardiotonic effect). In addition, however, the ouabain-Na + pump interaction activates protein kinase signaling pathways independent of pump inhibition. One result is the up-regulation of NCX expression in arterial smooth muscle, which also promotes Ca 2+ gain and contraction. This signaling function of ouabain also influences many other systems including the immune system, and kidney and liver development. The characterization of this novel hormone system is still in its infancy.
There are four molecular isoforms of the Na + pump α-subunit , α 1 to α 4 , which differ in their affinities for Na + and K + . These isoforms have been conserved during vertebrate evolution. All cells express α 1 and one other isoform; α 1 is responsible for maintaining the low [Na + ] i in “bulk” cytoplasm.
Expression of specific α-subunit isoforms is upregulated or downregulated under various physiological and pathophysiological conditions. For example, in the heart, thyroid hormone increases, and heart failure decreases α 2 expression. In kidney distal tubules, aldosterone upregulates α 1 , which then promotes Na + reabsorption. Also, several hormones such as dopamine, vasopressin, and serotonin (5-hydroxytryptamine [5-HT]), modulate the activity of the Na + pump in a tissue- and isoform-specific manner. These hormones activate or inactivate the pump by promoting phosphorylation of the pump at sites other than the site that is phosphorylated during ion transport. New understanding about the significance of the isoforms is beginning to emerge ( Box 11.2 and Fig. 11.3 ).
Intracellular Ca 2+ signaling is universal and is closely tied to Ca 2+ homeostasis
Intracellular Ca 2+ signaling (an increase in the free Ca 2+ ion concentration in the cytoplasm) is directly or indirectly involved in most cell processes, from sexual reproduction and cell division to cell death. Ca 2+ ions are crucial in the fertilization of the ovum, in muscle contraction, and in hormone and neurotransmitter secretion. Ca 2+ ions are also involved in the control of electrical excitability (e.g., through Ca 2+ -activated K + channels; Chapter 8 ) and in the regulation of many protein kinases, protein phosphatases, and other enzymes. Cell Ca 2+ overload usually leads to cell death, and protection from Ca 2+ overload may rescue damaged cells. Thus an appreciation of cell Ca 2+ homeostasis is essential for understanding many physiological and pathophysiological processes.
The Ca 2+ involved in cell signaling comes from the extracellular fluid (it may enter through a variety of Ca 2+ -permeable channels; Chapter 8 ) or from intracellular Ca 2+ stores in the endoplasmic reticulum (ER) or, in muscle, the sarcoplasmic reticulum (SR) . This “signal Ca 2+ ” must then either be extruded across the PM or be resequestered in the S/ER. The PM NCX, which couples Ca 2+ to Na + homeostasis, is described in Chapter 10 . Here we consider other mechanisms involved in Ca 2+ transport and their roles in Ca 2+ homeostasis.
Ca 2+ storage in the sarcoplasmic/endoplasmic reticulum is mediated by a Ca 2+ -ATPase
In Chapter 10 we noted that the cytosolic free (ionized) Ca 2+ concentration ([Ca 2+ ] i ) in most cells at rest is approximately 100 nM (10 −7 M or 0.0001 mM). The total intracellular Ca 2+ concentration is generally about 1000 to 10,000 times higher than this, however, or about 0.1 to 1 mM. Thus more than 98% of the intracellular Ca 2+ is sequestered in intracellular organelles, although a small amount is buffered (i.e., bound to cytoplasmic proteins, such as calmodulin, and to other molecules). The primary Ca 2+ storage site is the ER or SR, but a small amount is also normally concentrated in mitochondria. The S/ER is a system of interconnected tubules and sacs within the cytoplasm that plays a central role in Ca 2+ signaling. Some elements of the S/ER lie just beneath the PM and are specialized for Ca 2+ signal initiation or amplification. When cells are activated (e.g., by hormones, neurotransmitters, or depolarization), Ca 2+ is often released from the S/ER stores. This released Ca 2+ can trigger such processes as contraction and secretion ( Chapters 12 and 15 ). Subsequently, the Ca 2+ is resequestered in the S/ER.
This Ca 2+ sequestration is accomplished via an S/ER Ca 2+ pump, SERCA. SERCA uses one ATP to transport two Ca 2+ ions from the cytosol to the S/ER lumen and two protons (H + ions) from the lumen to the cytosol by a transport mechanism analogous to that of the Na + pump.
2Cacyt2++1 ATPcyt+2 HS/ER lumen+⇌2 CaS/ER lumen2++1 ADPcyt+1 Pi,cyt+2 Hcyt+